Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

PNC Financial Services Group Inc. raised its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the fourth ...

Professional Analyst Ratings for DexCom In the last month, 3 experts released ratings on this stock with an average target price of $96.33. Unusual Options Activity Detected: Smart Money on the ...

The recent selloff of U.S. equities continued at midday on fears the U.S. economy could be heading toward a recession. The Nasdaq sank 3%, the S&P 500 dipped about 2%, and the Dow Jones Industrial ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) ...

DexCom's growth is slowing ... The valuation of DXCM at 43x non-GAAP forward P/E and 7.5x forward price to sales does not adequately factor in these emerging risks. Given the current competitive ...

DexCom provides continuous glucose monitoring ... As time goes by, their share prices will continue rising, thereby netting you attractive capital gains as you witness a consistent increase ...

As time goes by, their share prices will continue rising ... expansion of around two percentage points this year and around 0.3 percentage points annually, with adjusted earnings per share ...